Indiana Jones Revisited

Nicholas Vardy

Nicholas Vardy has a unique background that has proven his knack for making money in different markets around the world.

Here’s a short refresher on the Millicom story. After ordering a strategic review of its business in January, Millicom put itself up for sale, entering into talks with half a dozen emerging-markets telecom players. It looked like China Mobile would emerge as the winner, but the deal fell through in early July when both parties got cold feet. The stock then dropped to $33. At the time, we were stopped out at a loss on the stock.

There’s been nothing but good news from Millicom ever since. At the end of July, the company announced that its revenues grew overall by 54%-78% in Central America alone — during the first half of 2006. EBITDA margins also improved by 53%. The first six months of this year also marked the first time that the company turned a profit.

Add to this upswing an eye-popping 64% increase in total subscribers to 10.9 million, and you can see why management had good reason to step away from the China Mobile deal. Millicom’s strong results only have increased the stock’s perceived value and the ultimate take of shareholders. Don’t be surprised if Millicom attracts a fresh bevy of suitors before the end of autumn. With global markets entering into a traditionally strong period, it’s a terrific time to bet on Millicom’s future.

So buy Millicom (MICC) at market today and place your sell stop at $33.75. For potentially quick double-digit percentage profits, buy the January $45 calls (CQDAI.X).

PORTFOLIO UPDATE

With a handful of our recommendations boasting double-digit percentage profits and global markets showing five straight days of gains, it’s time to take profits on certain holdings.

Exclusive  Buffett Calls a Bottom on the Market -- and So Do We

Acergy (ACGY) is up over 19% since July 24th for an annualized gain of 866%. Sell half of your remaining stock, and take your 88% profits on your remaining options. Tighten your stop to $16.25.

Cognizant Technologies (CTSH) is up 11.5% since early June. Sell your remaining options for just under a 60% gain. With our target price of $78, hold on to your stock, but tighten your stop to $64.50.

Mitsubishi UFJ (MTU) also is showing double-digit percentage gains of more than 11%. Sell half your November $12.50 call options to lock in a 40% gain.

Astra Zeneca (AZN) also has been a solid performer, with the stock up more than 5%. Take profits on all your October $60 call options for a 40% gain.

BHP Billiton (BHP) will announce what I expect to be strong results on Wednesday of this week. It’s also expected to announce a $3 billion share buyback. The combination of events should help to propel the stock upward.

We were stopped out of Northern European Oil Royalty Trust (NRT) last week, with a 5.4% gain over three short weeks.

Like This Article?
Now Get Our FREE Special Report:
Alternative Investing: Investing in Timber

Stock Investor editor Paul Dykewicz reveals why investing in timber may be one of the best long-term portfolio strategies you'll find today.

Get Access to the Report, 100% FREE


img
previous article

I've previously described Israeli generic pharmaceutical manufacturer Teva (TEVA) as the "Babe Ruth" of the global stocks. Since its IPO in 1991, Teva's stock is up over 52-fold. Yet, the old slugger had been showing its age lately. After peaking at almost $46 in January, Teva briefly dropped to below $30. But with the announcement of the Middle East ceasefire lifting the political pall over this Jerusalem-based company, Teva appears to have broken out of its recent slump.

PREMIUM SERVICES FOR INVESTORS

Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details

LEARN MORE HERE

Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details

LEARN MORE HERE

Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details

LEARN MORE HERE

Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details

LEARN MORE HERE

Mike Turner

Mike Turner’s financial, mathematical, computer science and engineering background serves as the foundation for his disciplined, rules-based approach to trading. Mike’s three services include:

Product Details

LEARN MORE HERE

Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Product Details

LEARN MORE HERE

DividendInvestor.com

Used by financial advisors and individual investors all over the world, DividendInvestor.com is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.

LEARN MORE HERE